Integrating Experimental and Analytic Approaches to Improve Data Quality in Genome-wide RNAi Screens

RNA interference (RNAi) not only plays an important role in drug discovery but can also be developed directly into drugs. RNAi high-throughput screening (HTS) biotechnology allows us to conduct genome-wide RNAi research. A central challenge in genome-wide RNAi research is to integrate both experimental and computational approaches to obtain high quality RNAi HTS assays. Based on our daily practice in RNAi HTS experiments, we propose the implementation of 3 experimental and analytic processes to improve the quality of data from RNAi HTS biotechnology: (1) select effective biological controls; (2) adopt appropriate plate designs to display and/or adjust for systematic errors of measurement; and (3) use effective analytic metrics to assess data quality. The applications in 5 real RNAi HTS experiments demonstrate the effectiveness of integrating these processes to improve data quality. Due to the effectiveness in improving data quality in RNAi HTS experiments, the methods and guidelines contained in the 3 experimental and analytic processes are likely to have broad utility in genome-wide RNAi research. (Journal of Biomolecular Screening 2008:378-389)

[1]  Robert Nadon,et al.  Statistical practice in high-throughput screening data analysis , 2006, Nature Biotechnology.

[2]  Xiaohua Douglas Zhang,et al.  Novel Analytic Criteria and Effective Plate Designs for Quality Control in Genome-Scale RNAi Screens , 2008, Journal of biomolecular screening.

[3]  K. Kang,et al.  Gene knockdown by large circular antisense for high-throughput functional genomics , 2005, Nature Biotechnology.

[4]  Thomas D. Y. Chung,et al.  A Simple Statistical Parameter for Use in Evaluation and Validation of High Throughput Screening Assays , 1999, Journal of biomolecular screening.

[5]  Zeger Debyser,et al.  HIV-1 Integrase Forms Stable Tetramers and Associates with LEDGF/p75 Protein in Human Cells* , 2003, The Journal of Biological Chemistry.

[6]  Bert Gunter,et al.  Improved Statistical Methods for Hit Selection in High-Throughput Screening , 2003, Journal of biomolecular screening.

[7]  Brian J Eastwood,et al.  A Comparison of Assay Performance Measures in Screening Assays: Signal Window, Z' Factor, and Assay Variability Ratio , 2006, Journal of biomolecular screening.

[8]  S. Haney.  Increasing the robustness and validity of RNAi screens. , 2007, Pharmacogenomics.

[9]  James Inglese,et al.  A cell-based β-lactamase reporter gene assay for the identification of inhibitors of hepatitis C virus replication , 2004 .

[10]  Min Xu,et al.  A genome wide analysis of ubiquitin ligases in APP processing identifies a novel regulator of BACE1 mRNA levels , 2006, Molecular and Cellular Neuroscience.

[11]  M. Lai,et al.  Human VAP-B Is Involved in Hepatitis C Virus Replication through Interaction with NS5A and NS5B , 2005, Journal of Virology.

[12]  Yunxia Sui,et al.  Alternative Statistical Parameter for High-Throughput Screening Assay Quality Assessment , 2007, Journal of biomolecular screening.

[13]  Xiaohua Douglas Zhang.  A pair of new statistical parameters for quality control in RNA interference high-throughput screening assays. , 2007, Genomics.

[14]  Wolfgang Huber,et al.  Analysis of cell-based RNAi screens , 2006, Genome Biology.

[15]  J. Dennis,et al.  Chemical enhancers of cytokine signaling that suppress microfilament turnover and tumor cell growth. , 2006, Cancer research.

[16]  Mengxiang Tang,et al.  Multiplex mRNA assay using electrophoretic tags for high-throughput gene expression analysis. , 2004, Nucleic acids research.

[17]  Nagesh Mahanthappa,et al.  Translating RNA interference into therapies for human disease. , 2005, Pharmacogenomics.

[18]  J H Zhang,et al.  Confirmation of primary active substances from high throughput screening of chemical and biological populations: a statistical approach and practical considerations. , 2000, Journal of combinatorial chemistry.

[19]  Bert Gunter,et al.  Statistical and Graphical Methods for Quality Control Determination of High-Throughput Screening Data , 2003, Journal of biomolecular screening.

[20]  N. Perrimon,et al.  Functional Genomic Analysis of the Wnt-Wingless Signaling Pathway , 2005, Science.

[21]  E. De Clercq,et al.  LEDGF/p75 Is Essential for Nuclear and Chromosomal Targeting of HIV-1 Integrase in Human Cells* , 2003, Journal of Biological Chemistry.

[22]  Michael Eisenstein,et al.  Microarrays: Quality control , 2006, Nature.

[23]  Shane D. Marine,et al.  LRRTM3 promotes processing of amyloid-precursor protein by BACE1 and is a positional candidate gene for late-onset Alzheimer's disease , 2006, Proceedings of the National Academy of Sciences.

[24]  Marc Ferrer,et al.  Median Absolute Deviation to Improve Hit Selection for Genome-Scale RNAi Screens , 2008, Journal of biomolecular screening.

[25]  Norbert Perrimon,et al.  Design and implementation of high-throughput RNAi screens in cultured Drosophila cells , 2007, Nature Protocols.

[26]  A. Fire,et al.  Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans , 1998, Nature.

[27]  Wulin Teo,et al.  An Essential Role for LEDGF/p75 in HIV Integration , 2006, Science.

[28]  Zhenbao Yu,et al.  High-throughput screening of effective siRNAs from RNAi libraries delivered via bacterial invasion , 2005, Nature Methods.

[29]  M. Manoharan,et al.  RNAi therapeutics: a potential new class of pharmaceutical drugs , 2006, Nature chemical biology.

[30]  C. Rice,et al.  Clearance of replicating hepatitis C virus replicon RNAs in cell culture by small interfering RNAs , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[31]  Andreas Schwienhorst,et al.  Thrombin inhibitors identified by computer-assisted multiparameter design. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[32]  Xiaohua Douglas Zhang.  Threshold Determination of Strictly Standardized Mean Difference in RNA Interference High Throughput Screening Assays , 2007, IMECS.

[33]  D. H. Besterfield.  Quality control , 1979 .

[34]  Shane D. Marine,et al.  High-Throughput Screening by RNA Interference: Control of Two Distinct Types of Variance , 2007, Cell cycle.

[35]  Marc Ferrer,et al.  Robust statistical methods for hit selection in RNA interference high-throughput screening experiments. , 2006, Pharmacogenomics.

[36]  N. Perrimon,et al.  Functional genomics reveals genes involved in protein secretion and Golgi organization , 2006, Nature.

[37]  Marc Ferrer,et al.  The Use of Strictly Standardized Mean Difference for Hit Selection in Primary RNA Interference High-Throughput Screening Experiments , 2007, Journal of biomolecular screening.

[38]  Xiaohua Douglas Zhang,et al.  A New Method with Flexible and Balanced Control of False Negatives and False Positives for Hit Selection in RNA Interference High-Throughput Screening Assays , 2007, Journal of biomolecular screening.

[39]  Reuven Agami,et al.  A large-scale RNAi screen in human cells identifies new components of the p53 pathway , 2004, Nature.